Macro- and Microvascular Function in Middle-Aged Individuals with Low Cardiovascular Disease Risk.

Sunni Patel, Hala Shokr, Adam Greenstein, Doina Gherghel
Author Information
  1. Sunni Patel: Vascular Research Laboratory, Ophthalmic Research Group, College Health and Life Sciences, Aston University, Birmingham B4 7ET, UK.
  2. Hala Shokr: Vascular Research Laboratory, Ophthalmic Research Group, College Health and Life Sciences, Aston University, Birmingham B4 7ET, UK. ORCID
  3. Adam Greenstein: Division of Cardiovascular Sciences, The University of Manchester, Manchester M13 9PL, UK.
  4. Doina Gherghel: Vascular Research Laboratory, Ophthalmic Research Group, College Health and Life Sciences, Aston University, Birmingham B4 7ET, UK. ORCID

Abstract

Aims: To investigate the microvascular function in apparently healthy individuals showing signs of early macrovascular endothelial dysfunction. Methods: Healthy participants aged between 30−55 years were recruited for the present study. Baseline measurements included body-mass index (BMI), waist-to-hip ratio (WHR), 24-h blood pressure, as well as fasted venous glucose, triglycerides (TG) and cholesterol (HDL, LDL and total). Brachial artery reactivity was measured using the flow-mediated dilation (FMD) technique and retinal vessel reactivity was assessed by using the Dynamic Retinal Vessel Analyser (DVA) in all individuals. The enrolled participants were separated in two groups, based on either a reduced (group 1: <5%—n = 53) or a normal FMD response (group 2: 7−10%—n = 47). Results: Individuals exhibiting reduced FMD responses showed a reduced baseline-corrected microvascular arterial dilation response to flickering light (p = 0.039). In addition, they also exhibited a reduced arteriolar maximum dilation (p = 0.034), as well as a longer dilation reaction time (p = 0.048) and a lower dilation amplitude (p = 0.042) when compared to those with normal FMD values. Conclusion: In otherwise healthy middle-aged individuals, early signs of vascular dysfunction are reflected simultaneously at both macro- and microvascular levels.

Keywords

References

  1. Hypertension. 2019 Jun;73(6):1138-1149 [PMID: 31067192]
  2. Chest. 2005 Jun;127(6):2254-63 [PMID: 15947345]
  3. Br J Ophthalmol. 2004 Jan;88(1):54-6 [PMID: 14693773]
  4. Graefes Arch Clin Exp Ophthalmol. 2004 May;242(5):377-92 [PMID: 14770317]
  5. Arthritis Res Ther. 2011 Jun 21;13(3):R99 [PMID: 21693023]
  6. Acta Ophthalmol. 2018 Dec;96(8):e956-e962 [PMID: 30198216]
  7. Acta Ophthalmol. 2015 Jun;93(4):e266-74 [PMID: 25487686]
  8. Eur Heart J. 2021 Jul 8;42(26):2590-2604 [PMID: 33257973]
  9. Biomedicines. 2022 Oct 21;10(10): [PMID: 36289930]
  10. Microvasc Res. 2019 Nov;126:103908 [PMID: 31376402]
  11. Nutrients. 2022 Jun 14;14(12): [PMID: 35745192]
  12. Diabetes Care. 2009 Aug;32(8):1536-41 [PMID: 19478197]
  13. Pathophysiology. 2008 Jun;15(1):49-67 [PMID: 18434105]
  14. Invest Ophthalmol Vis Sci. 2012 Aug 01;53(9):5102-8 [PMID: 22743316]
  15. J Am Coll Cardiol. 2002 Jan 16;39(2):257-65 [PMID: 11788217]
  16. Am J Physiol Heart Circ Physiol. 2011 Jan;300(1):H2-12 [PMID: 20952670]
  17. Circulation. 2002 Aug 6;106(6):640-2 [PMID: 12163419]
  18. Br J Ophthalmol. 2000 Nov;84(11):1285-90 [PMID: 11049956]
  19. Antioxidants (Basel). 2021 Nov 03;10(11): [PMID: 34829627]
  20. Microsc Res Tech. 2002 Jun 1;57(5):381-9 [PMID: 12112444]
  21. Acta Ophthalmol. 2021 Nov;99(7):e1236-e1242 [PMID: 33576186]
  22. Br Heart J. 1995 Sep;74(3):247-53 [PMID: 7547018]
  23. Cells. 2022 Sep 28;11(19): [PMID: 36230999]
  24. JRSM Cardiovasc Dis. 2019 Apr 11;8:2048004019843047 [PMID: 31007907]
  25. Anat Rec (Hoboken). 2014 Aug;297(8):1430-4 [PMID: 24841620]
  26. Am J Physiol Heart Circ Physiol. 2003 Aug;285(2):H631-6 [PMID: 12750062]
  27. Circ Cardiovasc Imaging. 2008 Sep;1(2):156-61 [PMID: 19808533]
  28. J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2935-2959 [PMID: 24239921]
  29. J Clin Endocrinol Metab. 1999 Jul;84(7):2329-35 [PMID: 10404798]
  30. Sci Rep. 2020 Mar 17;10(1):4881 [PMID: 32184402]
  31. Int J Cardiol. 2013 Sep 20;168(1):344-51 [PMID: 23041097]
  32. Acta Ophthalmol. 2016 Feb;94(1):e35-42 [PMID: 26149453]
  33. Invest Ophthalmol Vis Sci. 2011 Aug 03;52(9):6199-205 [PMID: 21474768]
  34. Ophthalmologe. 2005 Aug;102(8):787-93 [PMID: 15759121]
  35. Sci Rep. 2021 Feb 10;11(1):3473 [PMID: 33568754]
  36. N Engl J Med. 1996 Jan 18;334(3):150-4 [PMID: 8531969]

Word Cloud

Created with Highcharts 10.0.0dilation=microvascularFMDreducedp0individualsfunctionhealthysignsearlyendothelialdysfunctionparticipantswellreactivityusingflow-mediatedgroupnormalresponseIndividualsvascularAims:investigateapparentlyshowingmacrovascularMethods:Healthyaged30−55yearsrecruitedpresentstudyBaselinemeasurementsincludedbody-massindexBMIwaist-to-hipratioWHR24-hbloodpressurefastedvenousglucosetriglyceridesTGcholesterolHDLLDLtotalBrachialarterymeasuredtechniqueretinalvesselassessedDynamicRetinalVesselAnalyserDVAenrolledseparatedtwogroupsbasedeither1:<5%—n532:7−10%—n47Results:exhibitingresponsesshowedbaseline-correctedarterialflickeringlight039additionalsoexhibitedarteriolarmaximum034longerreactiontime048loweramplitude042comparedvaluesConclusion:otherwisemiddle-agedreflectedsimultaneouslymacro-levelsMacro-MicrovascularFunctionMiddle-AgedLowCardiovascularDiseaseRiskretina

Similar Articles

Cited By